stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / AMGN / Revenue

Amgen Inc. Revenue 2007–2025

Amgen Inc. (AMGN) annual revenue by fiscal year, computed from SEC filings. Compound growth +5.2%/yr over 18 years.

Fiscal yearRevenueChange (YoY)
FY 2025$36.75B+10.0%
FY 2024$33.42B+18.6%
FY 2023$28.19B+7.1%
FY 2022$26.32B+1.3%
FY 2021$25.98B+2.2%
FY 2020$25.42B+8.8%
FY 2019$23.36B-1.6%
FY 2018$23.75B+3.9%
FY 2017$22.85B-0.6%
FY 2016$22.99B+6.1%
FY 2015$21.66B+8.0%
FY 2014$20.06B+7.4%
FY 2013$18.68B+8.2%
FY 2012$17.27B+10.8%
FY 2011$15.58B+3.5%
FY 2010$15.05B+2.8%
FY 2009$14.64B-2.4%
FY 2008$15.00B+1.6%
FY 2007$14.77B

Source: Amgen Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Amgen Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Amgen Inc. — frequently asked questions

What is Amgen Inc.'s revenue?

Amgen Inc. (AMGN) reported revenue of $36.75B for fiscal year 2025, per its SEC filings.

How has Amgen Inc.'s revenue changed over time?

Between fiscal 2007 and 2025, AMGN's revenue grew at roughly 5.2% per year (compound annual rate), from $14.77B to $36.75B.

Where does this data come from?

Figures are computed from Amgen Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More AMGN financial history

Full AMGN fundamentals page → · All 1,500+ companies →